UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000059264
Receipt number R000067197
Scientific Title Data collection study on a fundus diagnosis support program using a portable fundus camera
Date of disclosure of the study information 2025/10/02
Last modified on 2025/10/02 10:28:57

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Data collection study on a fundus diagnosis support program using a portable fundus camera

Acronym

Data collection study on a fundus diagnosis support program using a portable fundus camera

Scientific Title

Data collection study on a fundus diagnosis support program using a portable fundus camera

Scientific Title:Acronym

Data collection study on a fundus diagnosis support program using a portable fundus camera

Region

Japan


Condition

Condition

glaucoma

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This study utilizes a handheld fundus camera for healthcare professionals to observe the fundus, collect images, and gather clinical information. This enables observation of fundus morphology differences associated with glaucoma presence and collects training and validation data (images and clinical information) for future development of an AI program supporting glaucoma diagnosis.

Basic objectives2

Others

Basic objectives -Others

Data collection research

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Not applicable (for data collection research)

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Age 18 or older at the time of consent acquisition (gender not specified)
2. Patients for whom written informed consent regarding participation in this study can be obtained
3. Patients deemed by a physician to be suitable candidates for examination of retinal diseases
3. Patients for whom a physician deems examination for retinal disease desirable

Key exclusion criteria

1. Patients determined by the principal investigator or co-investigator to be clearly at undue disadvantage by participating in the study
2. Patients determined by the principal investigator or co-investigator to clearly impede the conduct or evaluation of this clinical research by participating in the study

Target sample size

200


Research contact person

Name of lead principal investigator

1st name Sakaguchi
Middle name
Last name Hirokazu

Organization

Hiroshima University Hospital

Division name

Ophthalmology

Zip code

734-0037

Address

1-2-3, Kasumi, Minamiku, Hiroshima

TEL

082-257-5246

Email

sakaguh@hiroshima-u.ac.jp


Public contact

Name of contact person

1st name Kaori
Middle name
Last name Komatsu

Organization

Hiroshima University Hospital

Division name

Ophthalmology

Zip code

734-0037

Address

1-2-3, Kasumi, Minamiku, Hiroshima

TEL

082-257-5246

Homepage URL


Email

kaori110@hiroshima-u.ac.jp


Sponsor or person

Institute

Hirohsima University

Institute

Department

Personal name



Funding Source

Organization

AMED

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethical Committee for Clinical Research of Hiroshima University

Address

Kasumi 1-2-3 Minami-Ku, Hiroshima

Tel

082-257-1947

Email

iryo-sinsa@office.hiroshima-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 10 Month 02 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2025 Year 08 Month 04 Day

Date of IRB

2025 Year 09 Month 17 Day

Anticipated trial start date

2025 Year 10 Month 02 Day

Last follow-up date

2027 Year 07 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

This study collects the following existing information:
Patient background: Gender, date of birth, age, comorbidities, medical history, current medical history, eye drop usage status
Fundus examination*
Physical examination (slit-lamp microscopy and fundus examination)
Visual acuity test
Intraocular pressure measurement
Visual field test
Optical coherence tomography (OCT)
Confirmation of adverse events


Management information

Registered date

2025 Year 10 Month 02 Day

Last modified on

2025 Year 10 Month 02 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067197